Top 26 Enliven Therapeutics investors
The most complete profiles first. Showing 26 of 26.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Enliven Therapeutics investors are on Angel Roster?
Angel Roster lists 26 Enliven Therapeutics investors. 12 of them (46%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (21), Private Equity Firms (17) and Founder-Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Enliven Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (16) and Series A (5).
Where are Enliven Therapeutics investors based?
Most are based in the United States (23), Israel (2) and China (1).
Which companies have Enliven Therapeutics investors backed?
The most-backed portfolio companies among them are Cleave Therapeutics (26), Precision NanoSystem (16), Achaogen (16), TMRW Life Sciences (16) and Ensoma (16).
How do I contact Enliven Therapeutics investors?
Create a free Angel Roster account to search and filter all 26, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.